Occupational lung disease future or investigational therapies: Difference between revisions
No edit summary |
No edit summary |
||
(One intermediate revision by the same user not shown) | |||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{ | {{Adult bronchiolitis}} | ||
{{CMG}};{{AE}}{{HM}} | |||
==References== | ==References== | ||
Line 8: | Line 7: | ||
{{Reflist|2}} | {{Reflist|2}} | ||
[[Category:Pulmonology]] | [[Category:Pulmonology]] | ||
[[Category:Occupational diseases]] | [[Category:Occupational diseases]] | ||
[[Category: | [[Category:Medicine]] | ||
[[Category:Up-To-Date]] | |||
[[Category:Primary Care]] |
Latest revision as of 14:35, 15 March 2018
Adult bronchiolitis Microchapters |
Differentiating Occupational lung disease from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Occupational lung disease future or investigational therapies On the Web |
American Roentgen Ray Society Images of Occupational lung disease future or investigational therapies |
FDA on Occupational lung disease future or investigational therapies |
CDC on Occupational lung disease future or investigational therapies |
Occupational lung disease future or investigational therapies in the news |
Blogs on Occupational lung disease future or investigational therapies |
|
Risk calculators and risk factors for Occupational lung disease future or investigational therapies |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Hadeel Maksoud M.D.[2]